Author(s): Dr Tristen Ng, Dermatology Resident, Royal Perth Hospital, Australia (2024) Peer reviewed by: Dr Emily Wales, UK; Dr Libby Whittaker, Medical Writer, NZ (2024) Previous contributors: Hon A/Prof Amanda Oakley, Dermatologist, New Zealand (2014)
Folliculitis keloidalis, also called folliculitis keloidalis nuchae (FKN), is a chronic scarring folliculitis of the occipital scalp. It mostly affects men of African-Caribbean descent with black curly hair.
Folliculitis keloidalis is commonly called acne keloidalis nuchae (AKN), although the condition is not related to acne vulgaris, and the scars formed are not true keloid scars. Dermatitis papillaris capillitii is another synonym.
Small papules and nodules with overlying alopecia due to FKN
A pustule evident within an area of FKN
Papules and alopecia on the nape of the neck in FKN
Papules, nodules and keloid like scars on the nape
Dense scarring alopecia and tufting over the nape in advanced FKN
Folliculitis keloidalis mostly affects men of African-Caribbean descent with afro-textured hair, and may also affect men of Hispanic, Middle Eastern, Mediterranean, Asian, and Pacific descent. It is 20 times more common in men than women.
Onset occurs after adolescence and is rare after the age of 55 years.
The exact pathophysiology of folliculitis keloidalis is poorly understood but is thought to be exacerbated by mechanical injury and an aberrant immune response. Potential contributing factors include:
Skin injury — arising from very short haircuts, close shaving, or chronic trauma, such as friction from headgear or collars.
Hair texture — more greatly associated with coarse, wiry, and tightly curled hair, which can predispose to ingrown hairs and folliculitis.
Immune response
Pathogenic immune theory posits that intrafollicular antigens (eg, skin flora, Demodex, sebum, or cosmetics) stimulate an inflammatory reaction at the isthmus of the pilosebaceous unit.
This inflammatory response destroys the sebaceousgland and follicular wall, before progressing into the dermis and causing a follicular scar.
Hypertrophic scarring eventually develops due to the hair shaft fragments and degenerating epithelial components in the dermis.
Environmental factors — eg, heat and humidity.
Medications and other substances — eg, ciclosporin, calcineurin inhibitor, carbamazepine, anabolic steroids, or whey protein supplements.
Other factors — including excess androgen and seborrhoea.
Haircut-associated bleeding — can increase risk of infection and/or potential transmission of blood-borne diseases from shared barber equipment
How is folliculitis keloidalis diagnosed?
Folliculitis keloidalis is a clinical diagnosis based on the findings of papules, pustules, and keloid-like plaques on the occipital scalp and nape of the neck.
History
A thorough history should be obtained from the patient, including:
Age of onset of symptoms (post-puberty up to the fourth decade of life is typical) and rate of progression
Exacerbating factors eg, close clipping or shaving
Typical hairstyle and clothing choices
Any prior treatments and how well they worked.
Examination
Examine the entire scalp.
Normally the area of disease is limited to the posterior scalp and nape.
While folliculitis keloidalis can progress in a cranial direction, findings on other areas of the scalp should prompt consideration of differential diagnoses.
Dermoscopy may reveal perifollicular pustules and a white halo around the hair follicles in early-stage disease. Late-stage disease may show tufted ‘doll hairs’.
Investigations
Biopsy is rarely necessary unless the diagnosis is equivocal. If there is uncertainty, consider a punch biopsy, ideally including a suspected keloidal papule and the base of the hair follicle. The histology of folliculitis keloidalis nuchae is characteristic, should a biopsy be performed.
Other investigations may be indicated depending on the differential diagnoses and/or suspected complications eg, fungal or bacterial culture.
What is the differential diagnosis for folliculitis keloidalis?
What is the treatment for folliculitis keloidalis?
Folliculitis keloidalis can be challenging to treat, and there are no consensus guidelines regarding management. Early diagnosis and intervention can help to prevent progression and reduce scarring and hair loss. The following measures may be helpful.
General measures
Avoid picking, scratching, or rubbing the affected scalp.
Change barbering habits to avoid short and razor haircuts.
Minimise friction and irritation on the back of the neck eg, from headwear, sports gear, and high-collared shirts.
Consider using an antimicrobial cleanser or shampoo to reduce secondary infection.
Specific measures
Mild to moderate cases:
High-potency topical corticosteroids, often combined with topical retinoids (eg, adapalene, trifarotene, or tretinoin) — reassessing every 4–6 weeks and tapering once a good response is achieved (usually within 6–12 weeks)
A topical antimicrobial (eg, clindamycin-benzoyl peroxide) is sometimes added if pustules are present.
Secondary infection can complicate folliculitis keloidalis and may require additional antimicrobial therapy (guided by swab results). Intralesional corticosteroid administration is usually delayed until active bacterial infection is resolved.
How do you prevent folliculitis keloidalis?
While it isn’t known how to completely prevent folliculitis keloidalis in the first place, one of the key aims of management is to prevent disease progression by:
Avoiding potential exacerbating factors through lifestyle and behavioural modification
Treating keloidal scars early to prevent extension, confluent scarring, and hair loss.
What is the outcome for folliculitis keloidalis?
Folliculitis keloidalis should be treated early to ensure the best cosmetic outcome. If left untreated, the acneiformlesions may eventually converge and form large keloid-like scars, making treatment more challenging.
Bibliography
Cruz SA, Stein SL. A review of sports‐related dermatologic conditions. Transl Sports Med. 2020;3(4):300–308. doi: 10.1002/tsm2.145. Journal
Liebich C, Wergin VV, Schubert I, et al. Dermatoses in competitive athletes. Dtsch Z Für Sportmed. 2021;72(1):5–12. doi: 10.5960/DZSM.2020.466. Journal
Mackay-Wiggan JM, Husain S. Acne keloidalis nuchae: Management. Last updated Oct 26, 2021. UpToDate. Accessed Sept 7, 2024. Available here
Mackay-Wiggan JM, Husain S. Acne keloidalis nuchae: Pathogenesis, clinical manifestations, and diagnosis. UpToDate. Last updated Jul 3, 2024. Accessed Nov 4, 2023. Available here
Miteva M. Folliculitis Decalvans. In: Hair Pathology with Trichoscopic Correlations. CRC Press; 2021.
Ogunbiyi A. Acne keloidalis nuchae: prevalence, impact, and management challenges. Clin Cosmet Investig Dermatol. 2016;9:483–489. doi: 10.2147/CCID.S99225. Journal
Shavit E, Cohen A, Zoller L, et al. The burden of gout in acne keloidalis nuchae—Insights from a population-based study. J Cosmet Dermatol. 2023;22(1):284–288. doi: 10.1111/jocd.15476. Journal
Umar S, Sila CR. Acne keloidalis nuchae: A role for low-dose radiotherapy. JAAD Case Rep. 2021;13:90–93. doi: 10.1016/j.jdcr.2021.05.008. Article
Yip L, Barrett TH, Harries MJ. Folliculitis decalvans and lichen planopilaris phenotypic spectrum: a case series of biphasic clinical presentation and theories on pathogenesis. Clin Exp Dermatol. 2020;45(1):63–72. doi: 10.1111/ced.13989. Journal